BioCentury | Jan 8, 2015
Financial News

Follow-on roundup: Synageva, Five Prime, Cerus

...shares at $94.19 in a bumped up follow-on underwritten by Goldman Sachs; JPMorgan; Cowen; Baird; Nomura Securities...
BioCentury | Sep 15, 2014
Finance

Ribomic test in Tokyo

...on Sept. 25. The IPO is underwritten by Daiwa Securities, SMBC Nikko Securities, Mizuho Securities, Nomura Securities...
BioCentury | Sep 9, 2014
Financial News

Ribomic sets IPO range

...billion ($246.7 million). The IPO is underwritten by Daiwa Securities; SMBC Nikko Securities; Mizuho Securities; Nomura Securities...
BioCentury | Mar 7, 2014
Top Story

Synageva raises $211 million in follow-on

...when its share price was $103.99. Goldman Sachs; JPMorgan; Morgan Stanley; Cowen; Canaccord; Baird; and Nomura Securities...
BioCentury | Sep 2, 2013
Company News

Akorn, Hi-Tech Pharmacal deal

...and Kirkland & Ellis LLP and Polsinelli PC are acting as the company's legal advisors. Nomura Securities...
BioCentury | Sep 7, 2009
Company News

Sepracor, Dainippon Sumitomo deal

...offer will commence no later than Sept. 15 and is expected to close in 4Q09. Nomura Securities...
BioCentury | Sep 4, 2009
Top Story

Dainippon to acquire Sepracor for $2.6B

...III testing for schizophrenia. The deal was unanimously approved by the boards of both companies. Nomura Securities...
BioCentury | Jan 7, 2006
Financial News

CanBas raises $20 million

...led by NIF SMBC Ventures and Mitsui . Nikko antfactory; MBL Venture Capital; Mizuho Capital; Nomura Securities...
BioCentury | Dec 21, 2005
Financial News

Acologix raises $25.3 million

...led by Nomura R&A. Existing investors Tokio Marine & Nichido and JAIC and new investors Nomura Securities...
BioCentury | May 24, 2004
Emerging Company Profile

Acologix: Life after consulting

...year end. Last week, Acologix raised $39.6 million in a series B round led by Nomura Securities...
Items per page:
1 - 10 of 19
BioCentury | Jan 8, 2015
Financial News

Follow-on roundup: Synageva, Five Prime, Cerus

...shares at $94.19 in a bumped up follow-on underwritten by Goldman Sachs; JPMorgan; Cowen; Baird; Nomura Securities...
BioCentury | Sep 15, 2014
Finance

Ribomic test in Tokyo

...on Sept. 25. The IPO is underwritten by Daiwa Securities, SMBC Nikko Securities, Mizuho Securities, Nomura Securities...
BioCentury | Sep 9, 2014
Financial News

Ribomic sets IPO range

...billion ($246.7 million). The IPO is underwritten by Daiwa Securities; SMBC Nikko Securities; Mizuho Securities; Nomura Securities...
BioCentury | Mar 7, 2014
Top Story

Synageva raises $211 million in follow-on

...when its share price was $103.99. Goldman Sachs; JPMorgan; Morgan Stanley; Cowen; Canaccord; Baird; and Nomura Securities...
BioCentury | Sep 2, 2013
Company News

Akorn, Hi-Tech Pharmacal deal

...and Kirkland & Ellis LLP and Polsinelli PC are acting as the company's legal advisors. Nomura Securities...
BioCentury | Sep 7, 2009
Company News

Sepracor, Dainippon Sumitomo deal

...offer will commence no later than Sept. 15 and is expected to close in 4Q09. Nomura Securities...
BioCentury | Sep 4, 2009
Top Story

Dainippon to acquire Sepracor for $2.6B

...III testing for schizophrenia. The deal was unanimously approved by the boards of both companies. Nomura Securities...
BioCentury | Jan 7, 2006
Financial News

CanBas raises $20 million

...led by NIF SMBC Ventures and Mitsui . Nikko antfactory; MBL Venture Capital; Mizuho Capital; Nomura Securities...
BioCentury | Dec 21, 2005
Financial News

Acologix raises $25.3 million

...led by Nomura R&A. Existing investors Tokio Marine & Nichido and JAIC and new investors Nomura Securities...
BioCentury | May 24, 2004
Emerging Company Profile

Acologix: Life after consulting

...year end. Last week, Acologix raised $39.6 million in a series B round led by Nomura Securities...
Items per page:
1 - 10 of 19